Intra and postoperative intact parathyroid hormones has been embraced with enthusiasm by many surgeons as a means to detect patients with the highest risk of severe hypocalcaemia, but its major limitation for wider clinical use is the cost factor. Here, PTH is linked to Hypocalcemia.